You are here

  • Home
  • Archive
  • Volume 78, Issue 3
  • Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

Article metrics

Article menu
Vasculitis
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
Free

 

Online download statistics by month:

Online download statistics by month: January 2019 to February 2023

AbstractFullPdf
Jan 20196229697497
Feb 20193951574346
Mar 20192119413252
Apr 20191089208145
May 20191010172124
Jun 2019805169115
Jul 20191043189114
Aug 201973210673
Sep 20198469276
Oct 2019862117106
Nov 201972410878
Dec 20195777571
Jan 20205478971
Feb 20206077353
Mar 20205107460
Apr 20206158061
May 20207778263
Jun 202074392101
Jul 2020263244115
Aug 2020216204111
Sep 2020294276116
Oct 2020313305110
Nov 2020267256136
Dec 202023422689
Jan 2021225223124
Feb 2021201194113
Mar 2021208199125
Apr 2021229221129
May 2021230224133
Jun 2021229225139
Jul 2021212209121
Aug 2021205192134
Sep 2021247243108
Oct 2021227212107
Nov 2021276264135
Dec 202119418497
Jan 202219019298
Feb 202217216465
Mar 2022228230140
Apr 2022234236110
May 202219317985
Jun 202217416697
Jul 202218618166
Aug 202237037176
Sep 202217016586
Oct 202214514278
Nov 2022232215109
Dec 202213312757
Jan 202318818064
Feb 202314514058
Total30816101995737